The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms
Open accessAbstract
Mutations in the microtubule-associated protein tau gene have been linked to neurofibrillary tangle (NFT) formation in several neurodegenerative diseases known as tauopathies; however, no tau mutations occur in Alzheimer's disease, although this disease is also characterized by NFT formation and cell death. Importantly, the mechanism of tau-mediated neuronal death remains elusive. Aged mice expressing nonmutant human tau in the absence of mouse tau (htau mice) developed NFTs and extensive cell death. The mechanism of neuron death was investigated in htau mice, and surprisingly, the presence of tau filaments did not correlate directly with death within individual cells, suggesting that cell death can occur independently of NFT formation. Our observations show that the mechanism of neurodegeneration involved reexpression of cell-cycle proteins and DNA synthesis, indicating that nonmutant tau pathology and neurodegeneration may be linked via abnormal, incomplete cell-cycle reentry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, neuronal loss appears to be independent of tangle formation in some transgenic mouse models (12)(13)(14).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 4×
“A number of studies have detected DNA fragmentation, a hallmark of apoptosis, in AD tissue sections using the terminal deoxynucleotide transferase mediated dUTP nick-end labeling (TUNEL) method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to identify 3 -OH ends of broken DNA (Su et al.”
MethodInfluentialAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“However, no mutations have been found in the tau gene in AD, and the relationship between tau pathology, amyloid deposition, and neuronal degeneration is difficult to determine (Hardy and Higgins, 1992; Taylor et al., 2002).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“…life in specific brain regions, including the subventricular zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus (Eriksson et al., 1998; Gould et al., 1998), but it does not normally occur in most regions with large populations of postmitotic neurons.”
BackgroundHengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779 · cited 2×
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundThe Ki-67 protein: From the known and the unknown
Scholzen, T. E., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3 · Cited by 4,707
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“Mutations in the tau gene have been linked to NFT formation in a number of tauopathies in which no -amyloid deposits develop (Hutton et al., 1998; Spillantini et al., 1998; Poorkaj et al., 2001).”
BackgroundSelf-citationWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 1×
“The optical fractionator (West et al., 1991) was used to obtain quantitative estimates of neuronal loss with age in the htau mice.”
MethodFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,600 · cited 2×
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundMethodNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“Moreover, there is evidence to suggest that some neurons in AD brain may die without forming NFTs (Gomez-Isla et al., 1997).”
Background
Research works printed but not linked: 5
- 1989, Mol Cell Biol, 9, 1389
- Hof PR (2000) Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains. Amsterdam: Elsevier.
- 1996, Cancer Res, 56, 816
- 1996, Dementia, 7, 177
- 2003, Prog Cell Cycle Res, 5, 31
Cited by
Sorted by citations
Items 101–200 of 466
c-Abl in Neurodegenerative Disease
Schlatterer, S. D., Acker, C. M., & Davies, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9588-1 · Cited by 127
“Transgenic mice expressing human tau develop tau pathology, aberrant cell cycle re-entry in neurons, lateonset neurodegeneration, spatial memory deficits, and synaptic dysfunction (Andorfer et al. 2003, 2005; Polydoro et al. 2009).”
Self-citationVarvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., & Herrup, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39716 · Cited by 122
“Lack of specific amyloid-beta(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures.”
BackgroundPatterson, K. R., Ward, S. M., Combs, B., Voss, K., Kanaan, N. M., Morfini, G. A., Brady, S. T., Gamblin, T. C., & Binder, L. I. (2011) · Biochemistry · doi:10.1021/bi2009147 · Cited by 128
Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14406 · Cited by 125
“Finally, a recent study utilizing the previously discussed htau transgenic mice [4] showed that neuron death in aged animals occurred in cells that did not have direct evidence of NFT formation.”
Tau Phosphorylation by GSK3 in Different Conditions
Ávila, J., León‐Espinosa, G., García, E., García‐Escudero, V., Hernández, F., & DeFelipe, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/578373 · Cited by 119
“Also, there are some works suggesting that tau toxicity could be dependent in an increase in its expression [31] or that the toxicity could be related to its fragmentation, yielding some specific peptides [32], or to its aggregation, but this point is also discussed, since some works suggest a protective role for larg…”
BackgroundKnock-out and transgenic mouse models of tauopathies
Denk, F., & Wade‐Martins, R. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.010 · Cited by 128
“Thus, Andorfer and colleagues used electron microscopy in their human tau (htau) mice, and reported that the presence of tau filaments did not correlate with the death of individual cells (Andorfer et al., 2005).”
BackgroundMethodMinocycline reduces the development of abnormal tau species in models of Alzheimer's disease
Noble, W., Garwood, C., Stephenson, J., Kinsey, A. M., Hanger, D., & Anderton, B. (2009) · The FASEB Journal · doi:10.1096/fj.08-113795 · Cited by 123
“While the presence and density of NFTs correlates with cognitive decline in AD (2, 3), recent evidence indicates that NFTs are not neurotoxic, but that an earlier, abnormal tau species induces neurodegeneration (4, 5).”
BackgroundTau as a therapeutic target in neurodegenerative disease
Himmelstein, D. S., Ward, S., Lancia, J. K., Patterson, K. R., & Binder, L. I. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.001 · Cited by 122
“This mouse model displays early onset tau pathology and is generated by crossing hTau mice (Andorfer et al., 2005)withmice carrying theM146Lhumanpresenilin 1 (PS1)mutation (hTau/PS1) (Duff et al.”
Ramachandran, G., & Udgaonkar, J. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271874 · Cited by 143
Pang, K., Jiang, R., Zhang, W., Yang, Z., Li, L., Shimozawa, M., Tambaro, S., Mayer, J., Zhang, B., Li, M., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00582-x · Cited by 147
“Some transgenic models expressing human wild type or mutant tau also exhibit cell death.(77,78) However, the cell death could be detected in areas not relevant to AD, such as spinal cord.”
BackgroundJaworski, T., Lechat, B., Demedts, D., Gielis, L., Devijver, H., Borghgraef, P., Duimel, H., Verheyen, F., Kügler, S., & LEUVEN, F. V. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.025 · Cited by 121
“Similar cytoplasmic vacuolization in a human tau–expressing transgenic mouse model was interpreted to suggest a necrotic mechanism of decay, although other morphologic criteria implied more divergent pathways of cell death.(44) In our AAV-based model, dendrites and axoplasm of degenerating neurons appeared similarly d…”
ResultAre Tangles as Toxic as They Look?
Spires-Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., & Hyman, B. T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9566-7 · Cited by 104
“In fact, markers of cell death were not found in NFT bearing neurons in htau mice (Andorfer et al. 2005), indicating that cell death occurs independently of NFT.”
Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
Sigurdsson, E. M. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15202 · Cited by 116
“Compared to the homozygous P301L mice, the htau mice have a slower progression of pathology that more closely resembles AD [4,5,70] and may be more amenable to clearance.”
BackgroundP53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 130
“In AD, excessive DNA damage [22, 76, 104], altered DNA repair [49, 94], chromosomal abnormalities [98], senescence [123], lethal cell-cycle re-entry [2, 79, 121] and altered neuronal death [23, 24, 32, 68] have all been reported.”
BackgroundTransgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136
Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
Marlatt, M. W., & Lucassen, P. J. (2010) · Current Alzheimer Research · doi:10.2174/156720510790691362 · Cited by 91
Ambegaokar, S. S., & Jackson, G. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr432 · Cited by 113
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146
From tau phosphorylation to tau aggregation: what about neuronal death?
Buée, L., Troquier, L., Burnouf, S., Bélarbi, K., der Jeugd, A. V., Ahmed, T., Fernández-Gómez, F.-J., Caillierez, R., Grosjean, M., Bégard, S., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380967 · Cited by 99
Ljungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107
Tau Overexpression Results in Its Secretion via Membrane Vesicles
Simón, D., García‐García, E., Gómez‐Ramos, A., Falcón‐Pérez, J. M., Dı́az-Hernández, M., Hernández, F., & Ávila, J. (2012) · Neurodegenerative Diseases · doi:10.1159/000334915 · Cited by 99
Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo
Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2009.3 · Cited by 113
“been inconclusive, with mixed features of apoptosis, necrosis and autophagy being detected through a variety of histological and biochemical strategies, which are difficult to extrapolate to the dynamic events that occur in vivo.(23) The overlap between apoptosis and necrosis pathways has been linked to insult exposur…”
BackgroundAnti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
Garwood, C. J., Cooper, J. D., Hanger, D. P., & Noble, W. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00136 · Cited by 106
“Htau mice develop age-dependent tau pathology in the hippocampus and cortex (Andorfer et al., 2003, 2005), with the resulting neurodegeneration preceded by deficits in object recognition and spatial memory (Polydoro et al., 2009).”
BackgroundMethodInfluentialMicroglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Ávila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 134
Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD
Oblak, A. L., Forner, S., Territo, P. R., Sasner, M., Carter, G. W., Howell, G. R., Rizzo, S. J. S., Logsdon, B. A., Mangravite, L. M., Mortazavi, A., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12110 · Cited by 107
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104
“…the somato-dendritic compartment were achieved as early as 2 months of age (Andorfer et al. 2003), resulting in neuronal loss together with ventricle enlargement and reduced cortical thickness (Andorfer 2005), memory deficits and perturbed long-term potentiation at older age (Polydoro et al. 2009).”
BackgroundInfluentialNovel therapeutic strategies for the treatment of protein-misfolding diseases
Rochet, J. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000385 · Cited by 119
Ojala, J. O., Sutinen, E. M., Salminen, A., & Pirttilä, T. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.012 · Cited by 102
“Hyperphosphorylation of tau may also induce abnormal, incomplete neuronal cell cycle re-entry (Andorfer et al., 2005), but the role of inflammatory cytokines in the re-entry effort is unknown.”
BackgroundAzzini, E., Peña‐Corona, S. I., Hernández‐Parra, H., Chandran, D., Saleena, L. A. K., Sawikr, Y., Peluso, I., Dhumal, S., Kumar, M., Leyva‐Gómez, G., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8200 · Cited by 127
“Andorfer et al. (2005) observed a disparity between tangle burden and neuronal mortality in their investigation and similar illness models.”
BackgroundLuebke, J. I., Weaver, C. M., Rocher, A. B., Rodriguez, A., Crimins, J. L., Dickstein, D. L., Wearne, S. L., & Hof, P. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0244-2 · Cited by 113
“There is an apparent dissociation between the presence of an NFT and neuron death as demonstrated by Andorfer et al. (2005) who found that in htau mice (which overexpress wild-type human tau), substantial neuronal death precedes NFT formation, and dying neurons lack evidence of fibrillar tau…”
Self-citationWhittington, R. A., Bretteville, A., Dickler, M., & Planel, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.004 · Cited by 101
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 105
“Although the exact identity of the fragment is unknown, expression of an approximate recombinant version, tau [45-230], can lead to apoptosis in cell culture [118].”
BackgroundProtein Aggregation in the Aging Retina
Leger, F., Fernagut, P., Canron, M., Léoni, S., Vital, C., Tison, F., Bézard, E., & Vital, A. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820376cc · Cited by 104
“Moreover, it has been suggested that oligomeric forms of tau might be instrumental in neuronal death (15).”
BackgroundPluta, R. M., Jabłoński, M., Ułamek-Kozioł, M., Kocki, J., Brzozowska, J., Januszewski, S., Furmaga-Jabłońska, W., Bogucka‐Kocka, A., Maciejewski, R., & Czuczwar, S. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8439-1 · Cited by 100
“Other data demonstrated that neuronal death is coincided with neurofibrillary tangles [154], which are composed by hyperphosphorylated aggregates of the microtubuleassociated tau protein in some neurodegenerative disorders known as tauopathies, of which Alzheimer’s disease is one of the most notable.”
BackgroundWęgiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K.-C., Wegiel, J., Mazur‐Kolecka, B., Frackowiak, J., Mazur‐Kolecka, B., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318202bfa1 · Cited by 98
“On the other hand, Andorfer et al (68) showed that in human tau transgenic mice, PHF-containing neurons seem Bhealthy[ in terms of nuclear morphology, but speculations that the polymerization of hyperphosphorylated tau into fibrils is neuroprotective conflict with the neuronal nucleus misplacement and deformation and…”
BackgroundMarlatt, M. W., Potter, M. C., Bayer, T. A., van Praag, H., & Lucassen, P. J. (2013) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_237 · Cited by 92
“zone (SVZ) (Andorfer et al. 2005).”
Dickstein, D. L., Brautigam, H., Stockton, S. D., Schmeidler, J., & Hof, P. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0245-1 · Cited by 99
“As in humans, these mice accumulate hyperphosphorylated tau over time and develop NFTs in regions of the brain that are affected in the human disease (Andorfer et al. 2003, 2005).”
InfluentialSelf-citationTrimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
Tian, H., Davidowitz, E., Lopez, P., Emadi, S., Moe, J., & Sierks, M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/260787 · Cited by 90
“Similar to the important role of various soluble oligomeric Aβ species in AD, different soluble oligomeric forms of tau may also play a critical role in AD, also causing neuronal loss and cognitive dysfunction [19, 54, 55].”
BackgroundRosenmann, H., Grigoriadis, N., Eldar-Levy, H., Avital, A., Rozenstein‐Tsalkovich, L., Touloumi, O., Behar, L., Ben‐Hur, T., Avraham, Y., Berry, E., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.007 · Cited by 93
“Filamentous tau aggregates are present in brains of the DM tg mice EM studies of the sarcosyl insoluble fractions in DM tg mice of about 10 months of age revealed the presence of tau filaments stained with Tau13 as well as with CP13, indicating the aggregation of the human DM tau in a filamentous form, with evidence f…”
BackgroundMethodInfluentialHypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
Bretteville, A., Marcouiller, F., Julien, C., Khoury, N. B. E., Petry, F. R., Poitras, I., Mouginot, D., Lévesque, G., Hébert, S. S., & Planel, E. (2012) · Scientific Reports · doi:10.1038/srep00480 · Cited by 70
“The htau mice examined in this study were relatively young, given that the on onset of neurodegeneration in these mice occurs at approximately 14 months of age (Andorfer et al., 2005).”
Targeting Tau Protein in Alzheimerʼs Disease
Gong, C., Grundke, I., & Iqbal, K. (2010) · Drugs & Aging · doi:10.2165/11536110-000000000-00000 · Cited by 90
Murine models of Alzheimer's disease and their use in developing immunotherapies
Wısnıewskı, T., & Sigurdsson, E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.004 · Cited by 84
“To generate a more ideal model for AD, other researchers have used a single wild-type human tau to generate a transgenic model; however, most of these models did not develop NFTs, with the exception of two models: one expressing ON3R wild-type tau with a few NFTs in aged animals [116] and another with abundant NFTs th…”
MethodJaworski, T., Dewachter, I., Lechat, B., Croes, S., Termont, A., Demedts, D., Borghgraef, P., Devijver, H., Filipkowski, R. K., Kaczmarek, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007280 · Cited by 96
“Expression of cell cycle-related proteins fueled the hypothesis that post-mitotic neurons attempting to reactivate cell-cycling contribute to neurodegeneration in AD”
Mouse models of frontotemporal dementia
Roberson, E. D. (2012) · Annals of Neurology · doi:10.1002/ana.23722 · Cited by 103
“In both the rTg4510 and hTau lines, neuronal tau aggregates form, but neurons without aggregates are more susceptible to death.(75,76) Furthermore, in vivo imaging in rTg4510 mice suggests that tangle formation reduces the likelihood of cell death.”
BackgroundThe Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo
Loewen, C. A., & Feany, M. Β. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013084 · Cited by 92
“We have previously shown that tau-induced cell cycle reentry mediates neuronal apoptosis in the fly tauopathy model [20], a result that has been corroborated in rodent models model of tauopathy [32,33].”
ResultAdult Neurogenesis and Neurodegenerative Disease
Steiner, B., Wolf, S. A., & Kempermann, G. (2005) · Regenerative Medicine · doi:10.2217/17460751.1.1.15 · Cited by 87
Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
Majd, S., Power, J., & Majd, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00155 · Cited by 102
Snow, A. D., Cummings, J. A., & Lake, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.710683 · Cited by 84
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease
Rosa, E., Mahendram, S., Ke, Y. D., Ittner, L. M., Ginsberg, S. D., & Fahnestock, M. L. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.020 · Cited by 92
c‐Jun phosphorylation in Alzheimer disease
Thakur, A., Wang, X., Siedlak, S. L., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21298 · Cited by 80
“This is consistent with the recently achieved consensus that pathological structures like NFTs are not involved in neuronal death (Andorfer et al., 2005; Santacruz et al., 2005).”
ResultCook, C., Kang, S. S., Carlomagno, Y., Lin, W.-L., Yue, M., Kurti, A., Shinohara, M., Jansen-West, K., Perkerson, E., Castanedes-Casey, M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv336 · Cited by 82
“loss in our AAV-based model is in agreement with reports in other tau models, including the rTg4510 and humanized tau mousemodels (50,51), although future studieswill need to assess whether neuronal loss is observed in the AAV1-Tau model beyond 6 months of age.”
ResultIqbal, K., Alonso, A. D. C., & Grundke, I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14402 · Cited by 77
“[10] showed that in human tau transgenic mice, while there was widespread neurodegeneration, the PHF-containing neurons, however, appeared “healthy” in terms of nuclear morphology, suggesting that the polymerized protein was probably neuroprotective [10].”
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits
Velázquez, R., Ferreira, E., Tran, A., Turner, E. C., Belfiore, R., Branca, C., & Oddo, S. (2018) · Aging Cell · doi:10.1111/acel.12775 · Cited by 102
“However, removing endogenous mouse tau from these transgenic mice led to spatial memory deficits, perturbed LTP, as well as significant neuronal loss, ventricle enlargement, and reduced cortical thickness (Ando et al., 2011; Andorfer et al., 2005; Polydoro, Acker, Duff, Castillo & Davies, 2009).”
BackgroundSartori, M., Mendes, T., Desai, S., Lasorsa, A., Herledan, A., Malmanche, N., Mäkinen, P., Marttinen, M., Malki, I., Chapuis, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02017-9 · Cited by 72
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-β and prion peptides
Lopes, J. P., Oliveira, C. R., & Agostinho, P. M. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7506 · Cited by 66
Kinase activities increase during the development of tauopathy in htau mice
Kelleher, I., Garwood, C., Hanger, D. P., Anderton, B. H., & Noble, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04930.x · Cited by 78
“(2007) 103, 2256–2267 2007 The Authors with age and they develop PHF-containing NFT-like inclusions (Andorfer et al. 2003, 2005).”
BackgroundResultInfluentialBhaskar, K., Hobbs, G. A., Yen, S.-H., & Lee, G. S. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01103.x · Cited by 79
“Our finding is consistent with those reported in a mouse model expressing wild type tau where it was found that although PCNA was detected, it did not co-localize with tau pathology [19].”
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
“…assembly of tubulin (Amniai et al., 2009), disrupting axonal transport (Cuchillo-Ibanez et al., 2008), causing reentry of neurons into the cell cycle (Andorfer et al., 2005), and possibly leading to further abnormal tau processing, for example, truncation by proteases (Rametti et al., 2004) or…”
BackgroundAccelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model
Ando, K., Leroy, K., Héraud, C., Yilmaz, Z., Authelet, M., Suain, V., Decker, R. D., & Brion, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.034 · Cited by 80
Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
Thompson, A., Boekhoorn, K., Van Dam, A. ‐., & Lucassen, P. J. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00379.x · Cited by 73
“occurs after tau hyperphosphorylation in the mice around 9 months of age (Andorfer et al. 2005).”
BackgroundNaturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 93
Saman, S., Lee, N. C. Y., Inoyo, I. E., Jin, J., Li, Z., Doyle, T., McKee, A. C., & Hall, G. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132135 · Cited by 71
“Such functions include interactions with the plasma membrane [4-8], signal transduction (via the N terminal projection domain of tau) [7] and diverse developmental functions including the cell cycle [8], tissue patterning [9] neuronal polarization and axon identity [9-11] and various aspects of axonogenesis [12-16].”
The Neurotoxic Role of Extracellular Tau Protein
Sebastián‐Serrano, Á., de Diego-García, L., & Díaz-Hernández, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040998 · Cited by 85
“At this location, it is postulated that tau protein might play a relevant role in DNA protection [16] and in regulating the cell cycle [17].”
BackgroundLasagna‐Reeves, C. A., Sengupta, U., Castillo‐Carranza, D. L., Gerson, J. E., Guerrero‐Munoz, M. J., Troncoso, J. C., Jackson, G. R., & Kayed, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-56 · Cited by 78
“For instance, cell death and synaptic lesions occur independently of NFT formation in htau mice expressing nonmutant human tau [13,14].”
BackgroundAlzheimer's Disease and Anesthesia
Papon, M.-A., Whittington, R. A., Khoury, N. B. E., & Planel, E. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00272 · Cited by 70
“Surprisingly, hyperphosphorylation of tau in hTau transgenic mice expressing all six isoforms of human tau (Andorfer et al., 2003, 2005), led to the specific dissociation of tau from the MTs in old mice.”
Backgroundp53 prevents neurodegeneration by regulating synaptic genes
Merlo, P., Frost, B. E., Peng, S., Yang, Y. J., Park, P. J., & Feany, M. Β. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419083111 · Cited by 77
Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem
Gendreau, K. L., & Hall, G. F. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00160 · Cited by 67
“Studies in other tauopathy models have also called into question the role played by hyperphosphorylation in the chain of events leading to degeneration; recent fly model studies (159) have suggested that hyperphosphorylation can be neuroprotective by blocking other aspects of tau toxicity, such as apoptotic changes as…”
BackgroundMembrane trafficking in neuronal maintenance and degeneration
Wang, D., Chan, C., Cherry, S., & Hiesinger, P. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1201-4 · Cited by 74
“This notion leave open the possibilities that tau tangles further contribute to the pathology or function protectively or do both by transition from an initially protective reaction to a pathological process [101, 113, 122].”
BackgroundAneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease
Żekanowski, C., & Wojda, U. (2009) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2009-1748 · Cited by 74
Evidence for the Existence of a Secondary Pathway for Fibril Growth during the Aggregation of Tau
Ramachandran, G., & Udgaonkar, J. B. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.007 · Cited by 69
“transgenic mouse models of tauopathies have shown that cell death and cognitive deficits during tau aggregation are uncorrelated with fibril load, and hence, some early species is responsible for toxicity.(82,83) Future studies will hence address the possibility that fibril heterogeneity as a result of this newly disc…”
BackgroundIslam, F., Khadija, J. F., Harun-Or-Rashid, M., Rahaman, M. S., Nafady, M. H., Islam, M. R., Akter, A., Emran, T. B., Wilairatana, P., & Mubarak, M. S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5100904 · Cited by 85
“Recent studies have linked early modifications in the structures of soluble tau proteins, particularly their phosphorylation, to neurodegeneration [240, 241].”
Neurodegenerative Pathways in Alzheimer’s Disease: A Review
Ramachandran, A. K., Das, S., Joseph, A., Shenoy, G. G., Alex, A. T., & Mudgal, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200807130637 · Cited by 94
Neuronal c-Abl Overexpression Leads to Neuronal Loss and Neuroinflammation in the Mouse Forebrain
Schlatterer, S. D., Tremblay, M. A., Acker, C. M., & Davies, P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102025 · Cited by 65
Self-citationProtein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
Crespo‐Biel, N., Theunis, C., & LEUVEN, F. V. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/251426 · Cited by 69
“Moreover, protein Tau but not NFT appeared involved in neuronal death in transgenic mice and AD patients [44, 45].”
BackgroundTranscriptome profiling in neurodegenerative disease
Courtney, E., Kornfeld, S., Janitz, K., & Janitz, M. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.08.018 · Cited by 64
Alldred, M. J., Duff, K., & Ginsberg, S. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.022 · Cited by 61
Self-citationTherapeutic Strategies for Alzheimer’s Disease
Barten, D. M., & Albright, C. F. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8031-2 · Cited by 124
“number to account for the dramatic loss in neurons observed in this model [88].”
BackgroundHuman tau expression reduces adult neurogenesis in a mouse model of tauopathy
Komuro, Y., Xu, G., Bhaskar, K., & Lamb, B. T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.002 · Cited by 64
“The present studies sought to examine the effects of pathological MAPT on adult neurogenesis in the genomic-based hTau mouse model of tauopathy (Andorfer et al., 2003, 2005; Polydoro et al., 2009).”
Intracellular and extracellular tau
Ávila, J. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00049 · Cited by 63
“It has been suggested that as well as an increase in the amount of tau (Andorfer et al., 2005), structural changes to this protein, modifications by phosphorylation, or its aggregation could produce toxic effects in cells (Avila et al., 2004; Duff and Planel, 2005; Bretteville and Planel, 2008;…”
Kayed, R., & Jackson, G. R. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.001 · Cited by 56
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
Chen, D., Lan, G., Li, R., Mei, Y., Shui, X., Gu, X., Wang, L., Zhang, T., Gan, C., Xia, Y., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00302-4 · Cited by 68
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021) · Life · doi:10.3390/life11030229 · Cited by 55
Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
Walton, C. C., Begelman, D. V., Nguyen, W., & Andersen, J. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00129 · Cited by 62
Leugers, C. J., & Lee, G. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105387 · Cited by 60
Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
Kanungo, J., Zheng, Y., Amin, N. D., & Pant, H. C. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9410-6 · Cited by 60
“Tau hyperphosphorylation may also induce abnormal, incomplete cell cycle re-entry (Andorfer et al. 2005).”
Tau Phosphorylation, Aggregation, and Cell Toxicity
Ávila, J., Santa‐María, I., Pérez, M., Hernández, F., & Moreno, F. J. (2006) · BioMed Research International · doi:10.1155/jbb/2006/74539 · Cited by 62
“On the other hand, only the overexpression of wild-type human tau in a mouse is sufficient to cause tau phosphorylation, aggregation, and neural toxicity [43].”
BackgroundVaccination as a Therapeutic Approach to Alzheimer's Disease
Wısnıewskı, T., & Boutajangout, A. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20156 · Cited by 53
A neuroprotective role for the DNA damage checkpoint in tauopathy
Khurana, V., Merlo, P., DuBoff, B., Fulga, T. A., Sharp, K. A., Campbell, S. D., Götz, J., & Feany, M. Β. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00778.x · Cited by 58
“A number of studies have demonstrated DNA replication and cell cycle activation within postmitotic neurons in tauopathies, including Alzheimer’s disease and related disorders (Andorfer et al., 2005; Herrup & Yang, 2007).”
Neurobiological aspects of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.557363 · Cited by 47
“This pathology is very similar to that caused by misexpression of either mutant or wild-type tau in other models [31,32], emphasizing that multiple pathways affecting tau expression levels, dephosphorylation [33], and phosphorylation may Neurobiological aspects of Alzheimer’s disease”
BackgroundCopani, A., Caraci, F., Hoozemans, J., Calafiore, M., Sortino, M., & Nicoletti, F. (2007) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2006.10.016 · Cited by 57
“Correlative data have begun to accumulate in animal models of pathology, including APP-transgenic mouse models of AD [11-12], aged mice expressing non-mutant human tau [13], and Drosophila models of tauopathies [14].”
BackgroundSingle cell gene expression profiling in Alzheimer’s disease
Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76
“animal models of tauopathy and in postmortem human brains.(85,86,128,129,135) For example, quantitative analysis of hippocampal tissue sections double labeled for AO and TS demonstrates approximately 80% of TS-positive NFTs are AO-positive.”
BackgroundRamachandran, G., & Udgaonkar, J. B. (2013) · Biochemistry · doi:10.1021/bi400209z · Cited by 59
Alzheimer's disease: Old problem, new views from transgenic and viral models
Jaworski, T., Dewachter, I., Seymour, C. M., Borghgraef, P., Devijver, H., Kügler, S., & LEUVEN, F. V. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.03.005 · Cited by 49
“Noteworthy, introduction of the entire human MAPT gene in the mouse genome led to expression of all six human tau isoforms in neurons [53,54].”
BackgroundPerea, J. R., Ávila, J., & Bolós, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.007 · Cited by 54
“Recent research has shown that the most toxic form of Tau is not NFTs themselves, but rather the smaller aggregates, called Tau oligomers, which are likely to initiate neurodegeneration in tauopathies (Andorfer et al., 2005; Cowan and Mudher, 2013; Fox et al., 2011; Ishihara et al., 1999; Ishihara et al., 2001; Le Cor…”
BackgroundTrans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing
Avale, M. E., Rodríguez-Martín, T., & Gallo, J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt108 · Cited by 60
“4A), adult htau mice express all human tau isoforms, with an excess of 3R tau over 4R tau [(14, 15) and Fig.”
BackgroundTau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
Obulesu, M., Venu, R., & Somashekhar, R. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0475-5 · Cited by 53
“Studies have shown synaptic dysfunction in transgenic tau mice despite their inefficiency to unravel whether or not functional deficits precede the manifestation of NFTs [50, 60, 61].”
BackgroundInfluentialConejero‐Goldberg, C., Hyde, T. M., Chen, S., Dreses‐Werringloer, U., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.57 · Cited by 56
Self-citationTau acts as a mediator forAlzheimer's disease‐related synaptic deficits
Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53
“dying neurons often do not contain tangles (G omez-Isla et al., 1997; Andorfer et al., 2005; Spires et al., 2006).”
Backgroundvan Leeuwen, L. A. G., & Hoozemans, J. J. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1382-7 · Cited by 64
“Over the years, other experimental studies [57, 80], correlative evidence from post-mortem studies (Table 1), and the fact that cell cycle reactivation often accompanies Aβ-, and taumediated cell death have been supportive of this phenomenon [1, 22, 32, 43, 47].”
BackgroundWauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6
Metadata
- Authors
- Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P.
- Affiliations
- Albert Einstein College of Medicine (US)
- Icahn School of Medicine at Mount Sinai (US)
- Nathan Kline Institute for Psychiatric Research (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-01
- Volume
- 25
- Issue
- 22
- Pages
- 5446-5454
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6725006
- OpenAlex
- W2016758992
- Cited by
- 511
- References
- 74
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 10 · 2023: 28 · 2022: 18 · 2021: 16 · 2020: 26 · 2019: 17 · 2018: 20 · 2017: 20 · 2016: 17 · 2015: 22 · 2014: 29 · 2013: 25 · 2012: 26
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (38623)
- National Institute on Aging (R37AG022102, AG022102, R01AG022102)
- National Institute of Mental Health (38623)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- tau protein, cell cycle re-entry, neuronal cell death, neurofibrillary tangles, tauopathy, Alzheimer's disease, transgenic mice, neurodegeneration, DNA synthesis, tau filaments
- MeSH terms
- Aging, Animals, Brain, Bromodeoxyuridine, Cell Cycle, Humans, Mice, Transgenic, Nerve Degeneration, Nerve Tissue Proteins, Neurons, Neurofibrillary Tangles, tau Proteins, Cell Death, Protein Isoforms, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review